Clinical trial
Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated…
NCT00028613 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00028613 |
|---|---|
| Title | Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma |
| Official title | Phase I Safety Study Of 131I-Lym-1 For The Treatment Of Previously Treated Diffuse Large B-Cell Lymphoma |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Radiation |
| Interventions | iodine I 131 monoclonal antibody Lym-1 |
| Enrollment | 2 |
| Start date | Mar 1, 2001 |
| Primary completion | Oct 1, 2001 |
| Completion | Oct 1, 2001 |
| First posted | Jun 30, 2003 |
| Last update posted | Jan 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: